Shionogi & Co. Ltd.

12/12/2019 | Press release | Distributed by Public on 12/11/2019 19:04

NICE AND THE SMC HAVE PUBLISHED RECOMMENDATIONS ON SHIONOGI’S MULPLEO® (LUSUTROMBOPAG), APPROVING ITS USE FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH[...]